Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Everolimus × Genitourinary × Clear all

Phase

Status

Sponsor Class

OTHER 59 INDUSTRY 31 NIH 3 OTHER_GOV 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 4 Sarcoma 3 Breast 2 Thoracic 1 Other hematologic neoplasm 1 Lymphoid 1 Gynecologic 1 Genitourinary 1 Endocrine 1

Conditions

Kidney Neoplasms 1 Carcinoma, Renal Cell 1

Interventions

Radiotherapy 26 Docetaxel 21 Gemcitabine 20 bicalutamide 18 Paclitaxel 17 Goserelin 16 Cisplatin 16 Carboplatin 16 Doxorubicin 13 Leuprolide 12 Flutamide 12 Gene Expression Profiling 10 Radiotherapy, Conformal 9 Prednisone 9 Filgrastim 9 Vinblastine 8 Etoposide 8 Radiotherapy, Intensity-Modulated 7 Methotrexate 7 Gonadotropin-Releasing Hormone 7 Estramustine 7 Surgical Procedures, Operative 6 Radiation 6 Polymerase Chain Reaction 6 Ifosfamide 6 Buserelin 6 Androgen Antagonists 6 Amplified Fragment Length Polymorphism Analysis 6 Reverse Transcriptase Polymerase Chain Reaction 5 Fluorouracil 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01120249 2025-09-16

S0931

SWOG Cancer Research Network

Phase 3 Completed

1,545 enrolled 15 charts

Carcinoma, Renal Cell, Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡